Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Frequency of New Onset Seizures Amongst Adult Hospitalized Patients with COVID-19; A Systematic Review and Meta-Analysis
Epilepsy/Clinical Neurophysiology (EEG)
S24 - Epilepsy/Clinical Neurophysiology (EEG): Clinical Epilepsy (5:18 PM-5:30 PM)
010

Infection with COVID-19 has been associated with neurological complications such as headache, dizziness, peripheral neuropathy, and acute vascular events.  Acute onset seizures have been reported as a rare neurological complication in patients with COVID-19 infection.

The objective of this study is to determine the frequency of seizures in adult hospitalized patients with COVID-19 without a prior history of epilepsy.

PUBMED and EMBASE were searched from 12/01/2019 - 3/31/2021 in accordance with PRISMA guidelines, using the MESH terms ((Seizure) OR (Electroencephalography) OR (Status Epilepticus)) AND (COVID-19). The primary outcome was frequency of new onset seizure in hospitalized COVID-19 patients. Secondary outcomes were frequency of seizure in patients who had Electroencephalography (EEG) completed, risk of abnormal CerebroSpinal Fluid (CSF) results, and risk of abnormal imaging in patients with COVID-19.  An inverse variance meta-analysis of single proportions was performed using the double arcsine method. A random effects model was used due to high inconsistency within the studies.

Ninety-four studies identifying 333 patients with COVID-19 and new onset seizures were included. Frequency of new onset seizures in adult hospitalized patients with COVID-19 was 0.71% ([95% confidential interval]: [0.16-1.65], I2=89%, 147/28242 patients). Frequency of seizures in hospitalized COVID-19 patients who had EEG completed was 8.49% ([95% confidential interval]: [0.62-24.07], I2=14%, 44/535 patients). The risk of abnormal imaging by either CT head, MRI or vessel imaging was 43.85% ([95% confidential interval]: [17.47-72.27%], I2=58%, 58/128 patients). The risk of abnormal CSF results was 43.03% ([95% confidential interval]: [4.28-88.35], I2=41%, 28/58 patients).

The frequency of new onset seizures in patients with COVID-19 was 0.71% ([95% confidential interval]: [0.16-1.65], I2=89%, 147/28242 patients). Slightly less than half of COVID-19 patients with seizures had evidence of structural abnormalities on head imaging as a complication from infection. A small percentage of patients with COVID-19 and seizures were diagnosed with acute viral encephalitis.

Authors/Disclosures
Daniah Shamim, MD (University of Kansas Medical Center)
PRESENTER
Dr. Shamim has nothing to disclose.
No disclosure on file
Gary S. Gronseth, MD, FAAN (University of Kansas) Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain & Life. Dr. Gronseth has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as a Member/EBM consultant Guideline Development Subcommittee with AAN.